Janssen team partners with NHS to find dementia solutions

An entrepreneurial team within Janssen’s R&D operation is working with the NHS to promote innovative dementia care. Janssen Healthcare Innovation and the...

Sexual health in UK is worsening

Funding pressures on sexual health services are driving an increase in sexually transmitted infections (STIs) and unplanned pregnancies, a new report warns.

Mid Staffs report emphasises ‘transparency’

The public enquiry report on preventable deaths at Stafford General Hospital has placed emphasis on improving the ‘transparency’ and regulation of the NHS.

Local providers key for health and wellbeing boards

Health and wellbeing boards (HWBs) across the country will have to work closely with local providers of health and care services if they are to be successful, a new report warns.

Lords bill aims to restore Health Secretary’s duty to provide NHS

A new House of Lords bill aims to restore the legal duty of the Health Secretary to “secure provision” of NHS services.

DH plans rollout of personal health budgets

The Department of Health has outlined plans to make personal health budgets (PHBs) available to the 56,000 people receiving NHS continuing healthcare from April 2014.

QALY drug appraisal system found invalid

The Quality Adjusted Life Years (QALY) system for deciding which drugs should be available on the NHS is worthless, according to a European Commission report.

Board authorises second wave CCGs

The NHS Commissioning Board has authorised a further 67 clinical commissioning groups to take on local responsibilities for healthcare budgets and services.

UK to launch first shingles vaccination programme in Europe

The UK is launching the first national shingles immunisation programme in the EU.

UK Science Minister promoted AZ drug to NHS

UK Science Minister David Willetts intervened with NHS leaders to promote AstraZeneca’s anticoagulant Brilique (ticagrelor).

Latest articles

Samsung Bioepis Announces Three-year Follow-up Data for Biosimilar ONTRUZANT® (trastuzumab) in Early or Locally Advanced HER2-positive Breast Cancer

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab)

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab) in early or locally advanced HER2-positive breast cancer. Samsung Bioepis has announced the findings of...
Servier enters collaborative study with Harvard University researchers

Servier & Harvard researchers collaborate to develop therapeutics

Servier has entered into a collaborative study with Harvard University researchers to explore a new avenue for the treatment of type 2 diabetes and...
2019 HSJ Partnership Awards winners

2019 HSJ Partnership Awards winners

The 2019 HSJ Partnership Awards winners have been announced and they showcased effective partnership working within the NHS. With more than 700 NHS partners and...

Popular articles

pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
The future of genomics

The future of genomics and precision medicine

How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...

Market Access in practice: do you have a strategy?

This article is a little old... but if you're interested in Market Access we have plenty of new content: July 2018 Market Access Special Edition...
Kate Lancaster is the new RCOG Chief Executive

Kate Lancaster will be the new RCOG Chief Executive

Kate Lancaster, the Director of Strategy at East and North Hertfordshire NHS Trust will be the new RCOG Chief Executive.  The Royal College of Obstetricians...
Health experts alarmed at rise in joint health conditions.

UK launch of Jorveza announced for the treatment of EoE

Dr Falk Pharma UK announces the UK launch of Jorveza, the first globally licensed drug approved for the treatment of the immune mediated, chronic...